Investegate announcements from Oxurion NV, Oxurion Receives Transparency Notifications from Fidelity Management & Research Company LLC and Novartis Pharma AG
Leuven, Belgium, Boston, MA, US - March 17, 2022 - 07.00 PM CET - Oxurion NV(Euronext Brussels: OXUR) (the "Company" or "Oxurion"), a biopharmaceutical company developing next generation